We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.4B
AUM Growth
+$68.9M
Cap. Flow
-$31.6M
Cap. Flow %
-2.25%
Top 10 Hldgs %
26.53%
Holding
282
New
16
Increased
76
Reduced
95
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 22.46%
2 Healthcare 15.24%
3 Financials 8.38%
4 Industrials 8.09%
5 Consumer Discretionary 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
26
Stryker
SYK
$130B
$16.2M 1.15%
62,238
+65
+0.1% +$16.6K
MDY icon
27
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$15.7M 1.12%
32,029
-1,209
-4% -$596K
CRM icon
28
Salesforce
CRM
$158B
$15.7M 1.12%
64,183
+1,843
+3% +$425K
NEE icon
29
NextEra Energy
NEE
$177B
$15.1M 1.08%
206,724
+2,710
+1% +$203K
TEL icon
30
TE Connectivity
TEL
$62.6B
$14.5M 1.04%
107,540
+226
+0.2% +$30.3K
IJR icon
31
iShares Core S&P Small-Cap ETF
IJR
$112B
$14.4M 1.03%
127,524
-8,208
-6% -$916K
ADBE icon
32
Adobe
ADBE
$105B
$13.6M 0.97%
23,190
+71
+0.3% +$36.6K
CVS icon
33
CVS Health
CVS
$122B
$13.3M 0.95%
159,009
-824
-0.5% -$67.5K
MKC icon
34
McCormick & Company Non-Voting
MKC
$14.2B
$13M 0.93%
147,700
+612
+0.4% +$54.6K
VWO icon
35
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$13M 0.93%
240,024
-46,334
-16% -$2.47M
IDXX icon
36
Idexx Laboratories
IDXX
$46.2B
$12.9M 0.92%
20,448
-111
-0.5% -$61.3K
SEDG icon
37
SolarEdge
SEDG
$1.95B
$12.6M 0.9%
45,449
+9,868
+28% +$2.49M
DHR icon
38
Danaher
DHR
$144B
$12.3M 0.88%
51,626
-757
-1% -$168K
ABT icon
39
Abbott
ABT
$187B
$12M 0.85%
103,106
-203
-0.2% -$23.7K
QQQ icon
40
Invesco QQQ Trust
QQQ
$484B
$10.9M 0.78%
30,840
-2,271
-7% -$764K
PG icon
41
Procter & Gamble
PG
$339B
$10.7M 0.76%
79,315
-4,790
-6% -$648K
VGSH icon
42
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$10.3M 0.74%
167,885
-110,574
-40% -$6.8M
ABBV icon
43
AbbVie
ABBV
$435B
$9.9M 0.71%
87,891
-2,088
-2% -$235K
JPM icon
44
JPMorgan Chase
JPM
$950B
$9.89M 0.71%
63,574
-85
-0.1% -$13.3K
XBI icon
45
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$9.67M 0.69%
71,436
+7,173
+11% +$943K
PEP icon
46
PepsiCo
PEP
$190B
$9.64M 0.69%
65,083
-1,905
-3% -$278K
VCSH icon
47
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$9.11M 0.65%
110,171
-58,542
-35% -$4.84M
VTIP icon
48
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$9.1M 0.65%
173,688
-1,750
-1% -$91.2K
FLOT icon
49
iShares Floating Rate Bond ETF
FLOT
$10.3B
$8.81M 0.63%
173,357
-35,554
-17% -$1.81M
DLTR icon
50
Dollar Tree
DLTR
$25.2B
$8.79M 0.63%
88,369
-103
-0.1% -$11.2K

Similar funds

Boston Family Office's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Family Office held 282 positions worth $1.4B, up 5.2% from $1.33B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Family Office's Q2 2021 filing shows 16 new, 76 increased, 95 reduced and 4 closed positions. Its largest new stake was Root: 9,406 shares worth $1.83M. The largest sale was Sherwin-Williams, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Boston Family Office's largest Q2 2021 buy was Root: 9,406 shares worth $1.83M.
  • Boston Family Office added most to S&P Global in Q2 2021, an estimated $3.04M increase.
  • Boston Family Office's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $14.1M.
  • Boston Family Office fully exited Golar LNG in Q2 2021, selling an estimated $3.18M.
  • Boston Family Office's ten largest holdings make up 27% of its $1.4B portfolio in Q2 2021.
  • Boston Family Office opened 16 new positions and closed 4 in Q2 2021.
  • Boston Family Office's portfolio value rose 5.2% quarter-over-quarter to $1.4B.

Based on Boston Family Office's 13F filing for Q2 2021, filed 12 Aug 2021.